What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
Yutaka Kawakami focuses on Immunology, Antigen, Melanoma, Epitope and Tumor-infiltrating lymphocytes.
Yutaka Kawakami has researched Immunology in several fields, including Cancer and Peripheral blood mononuclear cell.
His Cancer study integrates concerns from other disciplines, such as Stage, Oncology and Pathology.
His research in Antigen intersects with topics in Cytotoxic T cell, Cancer research, Molecular biology and Immunotherapy.
The Melanoma study combines topics in areas such as T lymphocyte, HLA-A24, Immune tolerance, Melanoma Vaccine and Tumor antigen.
His Epitope research is multidisciplinary, incorporating perspectives in T cell, Adoptive cell transfer, Gene, CTL* and In vivo.
His most cited work include:
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma (1702 citations)
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor (1021 citations)
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. (856 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Cancer research, Antigen, Immunotherapy and Immune system are his primary areas of study.
His studies in Immunology integrate themes in fields like Cytotoxic T cell and Graft-versus-host disease.
His studies deal with areas such as Cancer cell, Cell and RNA interference as well as Cancer research.
His research investigates the connection between Antigen and topics such as Molecular biology that intersect with issues in cDNA library.
His study in Immunotherapy is interdisciplinary in nature, drawing from both Immunosuppression, Dendritic cell and Oncology.
His Melanoma research includes elements of Tumor-infiltrating lymphocytes, Tumor antigen and Melanoma-associated antigen.
He most often published in these fields:
- Immunology (40.55%)
- Cancer research (34.06%)
- Antigen (28.15%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (17.52%)
- Cancer research (34.06%)
- Oncology (10.83%)
In recent papers he was focusing on the following fields of study:
Yutaka Kawakami mostly deals with Internal medicine, Cancer research, Oncology, Immune system and Cancer.
Yutaka Kawakami combines subjects such as Cancer cell, T cell and Immunotherapy, Cancer immunotherapy with his study of Cancer research.
His work deals with themes such as Curcumin, Nude mouse and Antigen, which intersect with Cancer cell.
His work carried out in the field of Immunotherapy brings together such families of science as Oncogene, Melanoma and Cell therapy.
His Cancer research is multidisciplinary, incorporating elements of Antibody and Pharmacology.
In his study, which falls under the umbrella issue of Bevacizumab, Immunology is strongly linked to Cytotoxic T cell.
Between 2017 and 2021, his most popular works were:
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (665 citations)
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity (288 citations)
- Involvement of local renin‐angiotensin system in immunosuppression of tumor microenvironment (29 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Yutaka Kawakami mainly investigates Cancer research, Internal medicine, Immune system, Oncology and T cell.
His Cancer research research is multidisciplinary, relying on both Cancer cell, Lung cancer, Antibody and Tumor antigen.
As part of one scientific family, Yutaka Kawakami deals mainly with the area of Cancer cell, narrowing it down to issues related to the Cancer immunotherapy, and often Antigen, Curcumin and Nude mouse.
In his study, Graft-versus-host disease, Melanoma, Immunization, Humanized mouse and Neurosurgery is inextricably linked to Peripheral blood mononuclear cell, which falls within the broad field of Immune system.
The study incorporates disciplines such as Taxane, Regimen, Glioma, Vaccination and Immunotherapy in addition to Oncology.
His research integrates issues of Major histocompatibility complex, Vascular endothelial growth factor, Immunology and Microbiology in his study of Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
